Endogenous Mediators in Sepsis and Septic Shock

Advances in Clinical Chemistry

Volumn 33, Issue C, 1998, Pages 55-131

  Beishuizen, A ^a   Vermes, I ^a   Haanen, C ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN; HORMONE; NITRIC OXIDE; VASOCONSTRICTOR AGENT;

ANIMAL; BLOOD CLOTTING; HEMOSTASIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

ANIMALS; BLOOD COAGULATION; CYTOKINES; ENDOTHELINS; HEMOSTASIS; HORMONES; HUMANS; NITRIC OXIDE; SEPSIS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 0032234267     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(08)60206-1     Document Type: Article

References (464)

1. Aderka D. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: Potential new therapeutic implications. Isr. J. Med. Sci. 27 (1991) 52-60
2. Aderka D., Le J., and Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes U937 cells, and in mice. J. Immunol. 143 (1989) 3517-3521
3. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., and Polak J.M. Neuropeptide Y distribution in the rat brain. Science 221 (1983) 877-879
4. Al-Nawas B., Krammer I., and Shah P.M. Procalcitonin in diagnosis of severe infections. Eur. J. Med. Res. 1 (1996) 331-333
5. Anderson B.O., Bensard D.D., and Harken A.H. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg. Gynecol. Obstet. 172 (1991) 415-424
6. Araneo B.A., Shelby J., Li G.Z., Ku W., and Daynes R.A. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch. Surg. 128 (1993) 318-325
7. Aranow J.S., Zhuang J., Wang H., Larkin V., Smith M., and Fink M.P. A selective inhibition of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. Shock 5 (1996) 16-121
8. Arnalich F., Sánchez F.F., Martinez M., Jiménez M., López J., Vázques J.J., and Hernanz A. Changes in plasma concentrations of vasoactive neuropeptides in patients with sepsis and septic shock. Life Sci. 56 (1995) 75-81
9. Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M., and Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am. J. Hematol. 38 (1991) 281-287
10. Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M., and Matsuda T. Role of endothelin in disseminated intravascular coagulation. Am. J. Hematol. 41 (1992) 71-75
11. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., and Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infections. Lancet 341 (1993) 515-518
12. Ayala A., and Chaudry I.H. Platelet activating factor and its role in trauma, shock, and sepsis. New Horiz. 4 (1996) 265-275
13. Badr K.F. Sepsis-associated renal vasoconstriction: Potential targets for future therapy. Am. J. Kidney Dis. 20 (1992) 207-213
14. Balligand J.L., Ungureanu D., Kelly R.A., Kobzik L., Pimental D., Michel T., and Smith T.W. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91 (1993) 2314-2319
15. Barbarion A., de Marinis L., Tofani A., Casa S.D., D'Amico C., Mancini A., Corsello S.M., Sciuto R., and Barini A. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J. Clin. Endocrinol. Metab. 68 (1989) 523-528
16. 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem. J. 133 (1973) 709-724
17. Baulieu E.E. Dehydroepiandrosterone (DHEA): A fountain of youth?. J. Clin. Endocrinol. Metab. 81 (1996) 3147-3151
18. Baylis C., and Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int. 49 (1996) 1727-1731
19. Beale R., and Bihari D.J. Multiple organ failure: The pilgrim's progress. Crit. Care Med. 21 (1993) S1-S3
20. Beishuizen A., Gotz J.M., Kip L., Haanen C., and Vermes I. Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide. Med. Inflam. 1 (1992) 419-423
21. Bellomo R., Tipping P., and Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren. Fail. 17 (1995) 457-466
22. Ben-Jonathan N. Dopamine: A prolactin-inhibiting hormone. Endocr. Rev. 6 (1985) 564-589
23. Bensousan T.A., Garo B., Renault A., Morin J.F., and Boles J.M. Serum endogenous opioid peptides: Mortality predictive value in acutely ill patients. Lancet 344 (1994) 693
24. van den Berghe G., de Zegher F., and Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin. Endocrinol. 41 (1994) 731-737
25. van den Berghe G., de Zegher F., and Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit. Care Med. 22 (1994) 1747-1753
26. van den Berghe G., de Zegher F., Lauwers P., and Veldhuis J.D. Luteinizing hormone secretion and hypoandrogenemia in critically ill men: Effect of dopamine. Clin. Endocrinol. 41 (1994) 563-569
27. van den Berghe G., de Zegher F., Wouters P., Schetz M., Verwaest C., Ferdinande P., and Lauwers P. Dehydroepiandrosterone sulphate in critical illness: Effect of dopamine. Clin. Endocrinol. 43 (1995) 451-463
28. van den Berghe G., de Zegher F., Veldhuis J.D., Wouters P., Awouters M., Verbruggen W., Schetz M., Verwaest C., Lauwers P., Bouillon R., and Bowers C.Y. The somatotropic axis in critical illness: Effect of continous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J. Clin. Endocrinol. Metab. 82 (1997) 590-599
29. Bernard C. "Lecons sur les phenomenones de la vie communs aux animaux et aux vegetaux." (1878), Balliere et fils, Paris
30. Bernard G.R., Wheeler A.P., Russell J.A., Schein R., Summer W.R., Steinberg K.P., Fulkerson W.J., Wright P.E., Christman B.W., Dupont W.D., Higgins S.B., and Swindell B.B. The effects of ibuprofen on the physiology and survival of patients with sepsis. N. Engl. J. Med. 336 (1997) 912-918
31. Bernton E.W., Meltzer M.S., and Holaday J.W. Suppression of macrophage activation and T-lymphocyte function in hyperprolactinemic mice. Science 239 (1988) 401-404
32. Berr C., Lafont S., Debuire B., Dartigues J.F., and Ballieu E.E. Relationships of dehy-droepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study. Proc. Natl. Acad. Sci. USA 93 (1996) 13410-13415
33. Bertini R., Bianchi M., and Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167 (1988) 1708-1712
34. Besedovsky H.O., and Del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr. Rev. 17 (1996) 64-102
35. Beutler B., Milsark I.W., and Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effects of endotoxin. Science 229 (1985) 869-871
36. Beutler B., Krochin N., Milsark J.W., Luedke C., and Cerami A. Control of cachectin (tumor necrosis factor) synthesis; mechanisms of endotoxin resistance. Science 232 (1986) 977-980
37. Biemond B.J., Levi M., Ten Cate H., Soule H.R., Morris L.D., Foster D.L., Bogowitz C.A., Van der Poll T., Buller H.R., and Ten Cate J.W. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb. Haemost. 73 (1995) 223-230
38. Billiau A., and Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21 (1991) 559-573
39. Blackwell T.S., and Christman J.W. Sepsis and cytokines: Current status. Br. J. Anaesth. 77 (1996) 110-117
40. Bladon P.T., Rowlands T.E., Whittaker J.A., and Oakey R.E. Serum cortisol binding capacity measured with concanavalin A-Sepharose in patients with a recent inflammatory response. Clin. Chim. Acta 253 (1996) 9-20
41. De Boer J.P., Wolbink G.J., Thijs L.G., Baars J.W., Wagstaff J., and Hack C.E. Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharmacology 24 (1992) 135-148
42. De Boer J.P., Creasey A.A., Chang A., Abbink J.J., Roem D., Eerenberg A.J., Hack C.E., and Taylor F.B. Alpha-2 macroglobulin functions as an inhibitor of fibrinolytic, clotting and neutrophilic proteinases in sepsis: Studies using a baboon model. Infect. Immun. 61 (1993) 5035-5043
43. Boermeester M.A., van Leeuwen P.A.M., Coyle S.M., Wolbink G.J., Hack C.E., and Lowry S.F. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch. Surg. 130 (1995) 739-748
44. Boldt J., Menges T., Kuhn D., Diridis C., and Hempelman G. Alterations in circulating vasoactive substances in the critically ill-a comparison between survivors and nonsurvivors. Intensive Care Med. 21 (1995) 218-225
45. Bone R.C. Let's agree on terminology: Definitions of sepsis. Crit. Care Med. 19 (1991) 973-976
46. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115 (1991) 457-469
47. Bone R.C. Sepsis and coagulation. An important link. Chest. 101 (1992) 494-495
48. Bone R.C. Phospholipids and their inhibitors: A critical evaluation of their role in the treatment of sepsis. Crit. Care. Med. 20 (1992) 884-890
49. Bone R.C. Why sepsis trials fail. JAMA 276 (1996) 565-566
50. Bone R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response sydrome: What we do and do not know about cytokine regulation. Crit. Care Med. 24 (1996) 163-172
51. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Kanus W.A., Schein R.M.H., and Sibbald W.J. American College of Chest Physicians/Society of Critical Care Medicine Concensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20-6 (1992) 864-873
52. Bonnet F., Bilaine J., Lhoste F., Mankikiian B., Krdelhue B., and Rupin M. Naloxone therapy of human septic shock. Crit. Care Med. 13 (1985) 972-975
53. Bonte H.A., Vermes I., and van der Sluijs Veer G. Analytical and clinical evaluation of three sensitive thyrotropin assays. Ann. Clin. Biochem. 26 (1989) 508-512
54. Booke M., Hinder F., McGuire R., Traber L.D., and Traber D.L. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit. Care Med. 24 (1996) 835-844
55. Bradley J.R., Wilks D., and Rubenstein D. The vascular endothelium in septic shock. J. Infect. 28 (1994) 1-10
56. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilatator. Nature 313 (1985) 54-56
57. Brent G.A., and Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illness and low serum thyroxine concentration. J. Clin. Endocrinol. Metab. 63 (1986) 1-8
58. Brigham K.L. Role of free radicals in lung injury. Chest 89 (1986) 859-863
59. Brigham K.L., Meyrick B., Berry Jr. L.C., and Repine J.E. Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin. J. Appl. Physiol. 63 (1987) 840-850
60. Brizio-Molteni L., Molteni A., and Warpeha R.L. Prolactin, corticotropin, and gonadotropin concentrations following thermal injury in adults. J. Trauma 24 (1984) 1-7
61. Brouckaert P., Spriggs D.R., Demetri G., Kufe D.W., and Fiers W. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J. Exp. Med. 169 (1989) 2257
62. Broze G.J. Endothelial injury, coagulation, and atherosclerosis. Coron. Artery Dis. 2 (1991) 131-140
63. Broze G.J., Warren L.A., Novotny W.F., Higuchi D.A., Girard J.J., and Miletich J.P. The lipoprotein-associated coagulation inhibitor which inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71 (1988) 335-343
64. Brun-Buisson C., Doyon F., Carlet J., Dellamonica P., Gouin F., Lepoutre A., Mercier J.-C., Offenstadt G., and Regnier B. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 274 (1995) 968-974
65. Burger A.G., Engler D., Buergi U., Weissel M., and Steiger G. Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat. J. Clin. Invest. 71 (1983) 935-949
66. Cabin D.E., and Buchman T.G. Molecular biology of circulatory shock. Part III. Human hepatoblastoma (HepG2) cells demonstrate two patterns of shock-induced gene expression that are independent, exclusive, and prioritized. Surgery 108 (1990) 902-912
67. Calandra T., Gerain J., Heumann D., Baumgartner J.-D., and Glause M.P. High circulating levels of interleukin-6 in patients with septick shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 91 (1991) 23-28
68. Calandra T., Baumgartner J.D., Grau G.E., Wu M.M., Lambert P.H., Schellekens J., Verhoef J., and Glauser M.P. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161 (1990) 982-987
69. Canale D.D., and Donabedian R.K. Hypercalcitoninemia in acute pancreatitis. J. Clin. Endocrinol. Metab. 40 (1975) 738-740
70. Cannon J.G., Tompkins R.G., and Gelfland J.A. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161 (1990) 79-84
71. Cannon J.G., Nerad J.L., Poutsiaka D.D., and Dinarello C.A. Measuring circulating cytokines. J. Appl. Physiol. 75 (1993) 1897-1902
72. Cannon W.B. The emergency function of the adrenal medulla in pain and the major emotions. Am. J. Physiol. 33 (1914) 356-372
73. Carlos T., Swartz R., Kovach N.L., Yee E., Rosso M., Osborn L.C., Rosso G., Newman B., Lobb R., and Harlan J. Vascular cell adhesion molecule-1 (VCAM-1) mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 76 (1990) 965-970
74. Carson S.D., and Johnson D.R. Consecutive enzyme cascades: Complement activation at the cell surface triggers increased tissue factor activity. Blood 76 (1990) 361-367
75. Carvalho A.C., Demarinis S., Scott C.F., Silver L.D., Schmaier A.H., and Colman R.W. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J. Lab. Clin. Med. 112 (1988) 270-277
76. Casey L.C. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann. Thorac. Surg. 56 (1993) S92-S96
77. Casey L.C., Balk R.A., and Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119 (1993) 771-778
78. Ten Cate H., Levi M., Van der Poll T., Biemond B., Van Deventer D., Buller H., and Ten Cate J.W. Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications. Prog. Clin. Biol. Res. 388 (1994) 215-219
79. Chaudhri G., and Clark I.A. Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J. Immunol. 143 (1989) 1290-1294
80. Chopra I.J. Euthyroid sick syndrome: Is it a misnomer?. J. Clin. Endocrinol. Metab. 82 (1997) 329-334
81. Chopra I.J., Sakane S., and Chua Teco G.N. A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illness. J. Clin. Endocrinol. Metab. 72 (1991) 1113-1116
82. Chopra I.J., Chua Tec G.N., Mead J.F., Huang T.S., Beredo A., and Solomon D.H. Relationship between serum free fatty acid and thyroid binding inhibitor in nonthyroidal illness. J. Clin. Endocrinol. Metab. 60 (1985) 980-984
83. Christeff N., Auclair M.C., Benassayag C., Carli A., and Nunez E.A. Endotoxin-induced changes in sex steroid hormone levels in male rats. J. Steroid Biochem. 26 (1987) 67-71
84. Christeff N., Benassayag C., Carli-Vielle C., Carli A., and Nunez E.A. Elevated estrogen and reduced testosterone levels in the serum of male septic shock patients. J. Steroid Biochem. 29 (1988) 435-440
85. Cinat M.E., Waxman K., Granger G.A., Pearce W., Annas C., and Daughters K. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J. Am. Coll. Surg. 17 (1994) 529-537
86. Cohen J., and Carlet J. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit. Care Med. 24 (1996) 1431-1440
87. Colman R.W. The contact system and sepsis. Prog. Clin. Biol. Res. 388 (1994) 195-214
88. Colman R.W., and Schmaier A.H. The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions. Crit. Rev. Oncol. Hematol. 5 (1986) 57-85
89. Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M.B., and Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J. Clin. Invest. 71 (1983) 1893-1896
90. Cross A.S., Sadoff J.C., Kelly N., Bernton E., and Gemski P. Pretreatment with recombinant murine tumor necrosis factor-alpha/cachectin and murine interleukin 1-alpha protects mice from lethal bacterial infection. J. Exp. Med. 169 (1989) 2021-2027
91. Curzen N.P., Mitchell J.A., Jourdan K.B., Griffiths M.J.D., and Evans T.W. Endothelin-1-induced contraction of pulmonary arteries from endotoxemic rats is attenuated by the endohelin-A receptor antagonist, BQ123. Crit. Care Med. 24 (1996) 2007-2013
92. Damas P., Reuter A., Gysen P., Demonty J., Lamy M., and Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17 (1989) 975-978
93. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., and Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 79 (1994) 1605-1608
94. Danenberg H.D., Alpert G., Lustig S., and Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob. Agents Chemother. 36 (1992) 2275-2279
95. Darling G., Goldstein D.S., Stull R., Gorschboth C.M., and Norton J.A. Tumor necrosis factor: Immune endocrine interaction. Surgery 106 (1989) 1155-1160
96. Darville T., Giroir B., and Jacobs R. The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy. Infection 21 (1993) 279-290
97. Debets J.M.H., Kampmeijer R., van der Linden M.P.M.H., Buurman W.H., and van der Linden C.J. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit. Care Med. 17 (1989) 489-494
98. Deitcher S.R., and Eisenberg P.R. Elevated concentrations of cross-linked fibrin degradation products in plasma. An early marker of gram-negative bacteremia. Chest 103 (1993) 1107-1112
99. DeJoy S.Q., Jeyaseelan R., Torley L.W., Pickett W.C., Wissner A., Wick M.M., Oronsky A.L., and Kerwar S.S. Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis. J. Infect. Dis. 169 (1994) 150-156
100. DeLa Cadena R.A., Suffredini A.F., Kaufman N., Parrillo J.E., and Colman R.W. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 81 (1993) 3313-3317
101. Delomenie C., Wautier-Pepin M.P., Chappey O., and Wautier J.L. Modulation of human endothelial cell activation by anti-proliferative cytokines: Exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action. Exp. Cell Res. 257 (1993) 122-130
102. DeMaria A., Heffernan J.J., Grindlinger G.A., Craven D.E., McIntosh T.K., and McCabe W.R. Naloxone versus placebo in treatment of septic shock. Lancet 1 (1985) 1363-1365
103. DeRijk R.H., Van Rooijen N., Tilders F.J.H., Besedovsky H.O., Del Rey A., and Berkenbosch F. Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin. Endocrinology 129 (1991) 330-338
104. van Deuren M. Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) 12-16
105. van Deuren M., Dofferhoff A.S.M., and van der Meer J.W.M. Cytokines and the response to infection. J. Pathol. 168 (1992) 349-356
106. van Deventer S.J.H., Buller H.R., Ten Cate J.W., Aarden L., Hack E., and Sturk A. Endotoxin-induced biological effects: The role of cytokines. In: van Deventer S.J.H. (Ed). "Endotoxins in the Pathogenesis of Gram-Negative Septicemia" (1988), Albedon-Klop, Katwijk 113-128
107. De Vera M.E., Kim Y.M., Wong H.R., Wang Q., Billiar T.R., and Geller D.A. Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 24 (1996) 1238-1245
108. Devins S.S., Millerm A., Herndon B.L., O'Toole L., and Reisz G. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit. Care Med. 20 (1992) 1644-1649
109. Dinarello C.A., and Mier J.W. Lymphokines. N. Engl. J. Med. 317 (1987) 940-945
110. Dinarello C.A., Okusawa S., and Gelfland J.A. Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. "Molecular and Cellular Mechanisms of Septic Shock." (1989), Alan R. Liss, New York 243-263
111. Dinarello C.A., Aiura K., and Gelfland J.A. The role of interleukin-1 in septic shock. In: Vincent J.-L. (Ed). "Yearbook of Intensive Care and Emergency Medicine" (1992), Springer-Verlag, Berlin 25-35
112. Dinarello C.A., Ikejima T., Warner S.J.C., Orencole S.F., Lonneman G., Cannon J.G., and Libbey P. Interleukin 1 induces interleukin 1. J. Immunol. 139 (1987) 1902-1910
113. Dirkes K., Harris B.H., Connolly R.J., Schwaitzberg S.D., Dinarello C.A., and Gelfand J.A. Platelet activating factor-antagonist improves survival in experimental staphylococcal septicemia. J. Pediatr. Surg. 29 (1994) 1055-1057
114. Docter R., Krenning E.P., de Jong M., and Hennemann G. The sick euthyroid syndrome: Changes in thyroid hormone serum parameters and hormone metabolism. Clin. Endocrinol. 39 (1993) 499-518
115. Docter R., van Toor H., Krenning E.P., de Jong M., and Hennemann G. Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins. Clin. Chem. 39 (1993) 1668-1674
116. Dofferhoff A.S.M., Bom V.J.J., de Vries-Hospers H.G., van Ingen J., van der Meer J., Hazenberg B.P.C., Mulder P.O.M., and Weits J. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit. Care Med. 20 (1992) 185-192
117. Doherty A.M. Endothelin: A new challenge. J. Med. Chem. 35 (1992) 1493-1508
118. Donat Y.R.A., Slosman D.O., and Polla B.S. Oxidative injury and the heat shock response. Biochem. Pharmacol. 40 (1990) 2571-2577
119. Dosquet C., and Wautier J.L. Facteurs de contact au cours des états septiques graves. Presse Med. 21 (1992) 210-215
120. Doughty L.A., Kaplan S.S., and Carcillo J.A. Inflammatory cytokine and nitic oxide responses in pediatric sepsis and organ failure. Crit. Care Med. 24 (1996) 1137-1143
121. Drake T.A., Cheng J., Chang A.C., and Taylor F.B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am. J. Pathol. 142 (1993) 1458-1470
122. Durez P., Abramowicz D., Gerard C., van Mechelen M., Amraoui Z., Dubois C., Leo O., Velu T., and Goldman M. In vivo induction of interleukin-10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin. Am. J. Exp. Med. 177 (1993) 551-555
123. Durocher A., Gosset Ph., and Becg M.C. Tumor necrosis factor (TNF-α): A prognostic factor in patients with sepsis. Intensive Care Med. 16 (1990) S123
124. Ebeling P., and Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet 343 (1994) 1479-1481
125. Echtenacher B., Falk W., Mannel D.N., and Krammer P.H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145 (1990) 3762-3766
126. Ehrenreich H., Anderson R.W., Fox C.H., Rieckmann P., Hoffman G.S., Travis W.D., Coligan J.E., Kehrl J.H., and Fauci A.S. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med. 172 (1990) 1741-1748
127. Eison H.B., Reson M.J., Phillips R.A., and Krakoff L.R. Determinants of atrial natriuretic factor in the adult respiratory distress syndrome. Chest 94 (1988) 1040-1045
128. Ekins R. Validity of analog free thyroxin immunoassays. Clin. Chem. 33 (1987) 2137-2144
129. Elliott M.E., and Goodfriend T.L. Inhibition of aldosterone synthesis by atrial natriuretic factor. Fed. Proc. 45 (1986) 2376-2381
130. Endo S., Inada K., Inoue Y., Kuwata Y., Suzuki M., Yamashita H., Hoshi S., and Yoshida M. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ. Shock 38 (1992) 264-274
131. x) and cytokine levels in patients with septic shock. Res. Commun. Mol. Pathol. Pharmacol. 91 (1996) 347-356
132. Endo S., Inada K., Yamada Y., Takakuwa T., Nakae H., Kasai T., Koike S., Inoue Y., Niimi M., Wakabayashi G., and Taniguchi S. Functional modification of vascular endothelial cells by cytokines during septic shock. Res. Commun. Mol. Pathol. Pharmacol. 96 (1996) 23-38
133. Engel A., Kern W.V., Mürdter G., and Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection 22 (1994) 160-164
134. Engelberts I., von Asmuth E.J.U., van der Linden C.J., and Buurman W.A. The interrelation between TNF, IL-6 and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res. 10 (1991) 127-131
135. Engelberts I., Möller A., Schoen G.J.M., van der Linden C.J., and Buurman W.A. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 10 (1990) 69-76
136. Engelberts I., Stephens S., Francot G.J.M., van der Linden C.J., and Buurman W.A. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338 (1991) 515-516
137. Ertel E., Keel M., Steckholzer U., Ungethum U., and Trentz O. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch. Surg. 131 (1996) 51-56
138. Esmon C.T. The protein C anticoagulant pathways. Arterioscler. Thromb. 12 (1992) 135-145
139. Faden A.I., and Holiday J.W. Naloxone treatment of endotoxin shock: Stereospecificity of physiologic and pharmacologic effects in the rat. J. Pharmacol. Exp. Ther. 212 (1980) 414-417
140. Farrell A.J., and Blake D.R. Nitric oxide. Ann. Rheum. Dis. 55 (1996) 7-20
141. Feldman D., Mondon C.E., Horner J.A., and Weiser J.N. Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Am. J. Physiol. 237 (1979) E493-E499
142. Felicetta J.V., Green W.L., and Nelp W.B. Inhibition of hepatic binding of thyroxine by cholecystographic agents. J. Clin. Invest. 65 (1980) 1032-1040
143. Findling J.W., Waters V.O., and Raff H. The dissociation of renin and aldosterone during critical illness. J. Clin. Endocrinol. Metab. 64 (1987) 592-595
144. Fink M.P., and Payen D. The role of nitric oxide in sepsis and ARDS: Synopsis of a round-table conference held in Brussels on 18-20 March 1995. Intensive Care Med. 22 (1996) 158-165
145. Fink A., Geva D., Zung A., Konichezky S., Eliraz A., and Bentwich Z. Adult respiratory distress syndrome: Roles of leukotriene, C4 and platelet activating factor. Crit. Care Med. 18 (1990) 905-910
146. Fioretino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147 (1991) 3815-3822
147. Fischer E., Van Zee K.J., Marano M.A., Rock C.S., Kenney J.S., Poutsiaka D.B., Dinarello C.A., Lowry S.F., and Moldawer L.L. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79 (1992) 2196-2200
148. Fischer E., Marano M.A., van Zee K.J., Rock C.S., Hawes A.S., Thompson W.A., De-Forge L., Kenney J.S., Remick D.G., Bloedow D.C., Thompson R.C., Lowry S.F., and Moldawer L.L. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock. J. Clin. Invest. 89 (1992) 1551-1557
149. Fleshner M., Deak T., Spencer R.L., Laudenslager M.L., Watkins L.R., and Maier S.F. A long term increase in basal levels of corticosterone and a decrease in corticosterone-binding globulin after acute stressor exposure. Endocrinology 136 (1995) 5336-5342
150. Flores E.A., Bistrian B.R., Pomposelli J.J., Dinarello C.A., Blackburn G.L., and Istfan N.W. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J. Clin. Invest. 83 (1989) 1614-1622
151. Förstermann U., and Kleinert H. Nitric oxide synthase: Expression and expressional control of the three isoforms. Arch. Pharmacol. 352 (1995) 351-364
152. Fourrier F., Jourdain M., Tournois A., Caron C., Goudemand J., and Chopin C. Coagulation inhibitor substitution during sepsis. Intensive Care Med. 21 Suppl 2 (1995) S264-S268
153. Fourrier F., Jallot A., Leclerc L., Jourdain M., Racadot A., Chagnon J.L., Rime A., and Chopin C. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ. Shock 43 (1994) 171-178
154. De Fouw N.J., Van Hinsbergh V.W.M., De Jong Y.F., Haverkate F., and Bertina R.M. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells. Thromb. Haemost. 57 (1987) 176-182
155. Frayn K.N. Hormonal control of metabolism in trauma and sepsis. Clin. Endocrinol. 24 (1986) 577-599
156. Frieling J.T.M., van Deuren M., Wijdenes J., van Dalen R., Bartelink A.K.M., van der Linden C.J., and Sauerwein R.W. Interleukin-6 and its soluble receptor during acute meningococcal infections: Effect of plasma or whole blood exchange. Crit. Care Med. 24 (1996) 1801-1805
157. Friedland J.S., Suputtamongkol Y., Remick D., Chaowagul W., Strieer R.M., Kunkel S.L., White N.J., and Griffing G.E. Prolonged evaluation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect. Immun. 60 (1992) 2402-2408
158. Fukata J., Imura H., and Nakao K. Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function. J. Endocrinol. Invest. 16 (1993) 141-155
159. Fukuda Y., Hirata Y., Yoshimi H., Kojima T., Kobayashi Y., Yanagisawa M., and Masaki T. Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem. Biophys. Res. Commun. 155 (1988) 167-172
160. Gadina M., Bertini R., Mengozzi M., Zandalasini M., and Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J. Exp. Med. 173 (1991) 1305-1310
161. Gala R.R. The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat. Life Sci. 46 (1990) 1407-1420
162. Gando S., Kameue T., Nanzaki S., and Nakanishi Y. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thomb. Res. 80 (1995) 519-526
163. Gardlund B., Sjölin J., Nilsson A., Roll M., Wickerts C.-J., and Wretlind B. Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity. J. Infect. Dis. 172 (1995) 296-301
164. Gasic A.C., McGuire G., Krater S., Farhood A.I., Goldstein M.A., Smith C.W., Entman M.L., and Taylor A.A. Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 84 (1991) 2154-2166
165. Gazzinelli R.T., Oswald I.P., James S.L., and Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J. Immunol. 148 (1992) 1792-1796
166. Gebhart S.S.P., Watts N.B., Clark R.V., Umpierrez G., and Sgoutas D. Reversible impairment of gonadotrophin secretion in critical illness. Arch. Intern. Med. 149 (1989) 1637-1641
167. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., and Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177 (1993) 547-550
168. Gindoff P.R., and Ferin M. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in primate. Endocrinology 121 (1987) 837-842
169. Girardin E., Roux-Lombard P., Grau G.E., Suter P., Gallati H., and Dayer J.M. The J5 Study Group. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76 (1992) 20-23
170. Giri J.G., Wells J., Dower S.K., McCall C.E., Guzman R.N., Slack J., Bird T.A., Shanebeck K., Grabstein K., Sims J.E., and Alderson M.R. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor regulation of IL-1 responses. J. Immunol. 153 (1994) 5802
171. Glauser M.P., Zanetti G., Baumgartner J.-D., and Cohen J. Septic shock: Pathogenesis. Lancet 338 (1991) 732-735
172. Goetz K.L. Physiology and pathophysiology of atrial peptides. Am. J. Physiol. 254 (1988) E1-E15
173. Goetz K.L., Wang B.C., Madwed J.B., Zhu J.L., and Leadley R.J. Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255 (1988) R1064-R1068
174. Goldberg L.I. Dopamine-clinical use of an endogenous catecholamine. N. Engl. J. Med. 291 (1974) 707-710
175. Goldie A.S., Fearon K.C.H., Ross J.A., Barclay G.R., Jackson R.E., Grant I.S., Ramsay G., Blyth A.S., and Cameron Howie J. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 274 (1995) 172-177
176. Goode H.F., and Webster N.R. Free radicals and antioxidants in sepsis. Crit. Care Med. 21 (1993) 1770-1776
177. Gottardis M., Nigitsch C., Schmutzhard E., Neumann M., Putensen C., Hackl J.M., and Koller W. The secretion of human growth hormone stimulated by human growth hormone releasing factor following severe cranio-cerebral trauma. Intensive Care Med. 16 (1990) 163-166
178. Gramm H.J., Dollinger P., and Beier W. Procalcitonin-ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis. Chir. Gastroenterol. 1 Suppl 2 (1995) 51-54
179. Gregor J.S., Carlon G.W., and Howland W.S. Naloxone in septic shock. Crit. Care Med. 11 (1983) 650-654
180. De Groot P.G., Gonsalves M.D., Loesberg C., Van Buul-Wortelboer M.F., Van Aken W.G., and Van Mourik J.A. Thrombin-induced release of von Willebrand factor from endothelial cells is mediated by phospholipid methylation. J. Biol. Chem. 259 (1984) 13329-13333
181. De Groote M.A., Martin M.A., Densen P., Pfaller M.A., and Wenzel R.P. Plasma tumor necrosis factor levels in patients with presumed sepsis. JAMA 262 (1989) 249-251
182. Haanen C., Holdrinet A., and Wijdeveld P. In: Gessler U. (Ed). "Pathogenesis and Clinical Findings with Renal Failure" (1971), Georg Thieme Verlag, Stuttgart 132-139
183. Haanen C. Disseminated intravascular coagulation and its impact on blood transfusion. In: Smit Sibinga C.Th., Das P.C., and van-Loghem J.J. (Eds). "Blood Transfusion and Problems of Bleeding" (1982), Martinus Nijhoff, The Hague 133-145
184. Haanen, C., Early manifestations and minor forms of intravascular clotting in men. In: "Proc. Dijkzigt Conference" (G. Den Ottolander, ed.), Int. Cong. Ser. 123, Excerpta Med., Amsterdam, 31-34 (1996)
185. Hack C.E., and Dors D. Activation and inhibition of factor XII (Hageman factor) in vivo. Curr. Opin. Invest. Drugs 1 (1992) 95-110
186. Hack C.E., Nuijens J.H., Strack van Schijndel R.J.M., Abbink J.J., Eerenberg A.J.M., and Thijs L.G. A model for the interplay of inflammatory mediators in sepsis: A study in 48 patients. Intensive Care Med. 16 (1990) s187-s191
187. Hack C.E., Ogilvie A.C., Eisele B., Jansen P.M., Wagstaff J., and Thijs L.G. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Prog. Clin. Biol. Res. 388 (1994) 335-357
188. Hack C.E., Wagstaff J., Strack Van Schijndel R., Eerenberg A., Pinedo H., Thijs L., and Nuijens J. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: Implications for septic shock. Thromb. Haemost. 65 (1991) 497-503
189. Hack C.E., Hart M., Strack van Schijndel R.J.M., Eerenberg A.J., Nuijens J.H., Thijs L.G., and Aarden L.A. Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect. Immun. 60 (1992) 2835-2842
190. Hack C.E., Groot de E.R., Felt-Boersma R.J.F., Nuijens J.H., Strack van Schijndel R.J.M., Eerenberg-Belmer A.J.M., Thijs L.G., and Aarden L.A. Increased plasma levels of interleukin-6 in sepsis. Blood 74 (1989) 1704-1710
191. Hack C.E., Nuijens J.H., Feit-Bersma R.J.F., Schreuder W.O., Eerenberg-Beimer A.J.M., Paardekooper J., Bronsveld W., and Thijs L.G. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am. J. Med. 86 (1989) 20-26
192. Haglund U. Systemic mediators released from the gut in critical illness. Crit. Care Med. 21 (1993) S15-S18
193. Halstensen A., Ceska M., Brandtzaeg P., Redl H., Naess A., and Waagem A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167 (1993) 471-475
194. Hamilton G., Hofbauer S., and Hamilton B. Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand. J. Infect. Dis. 24 (1992) 361-368
195. Hammond G.L. Potential functions of plasma steroid-binding proteins. Trends Endocrinol. Metab. 6 (1995) 298-304
196. Hammond G.L., Smith C.L., and Underhill D.A. Molecular studies of corticosteroid binding globulin structure, biosynthesis, and function. J. Steroid Biochem. Mol. Biol. 40 (1991) 755-767
197. Harbour D.V., Galin F.S., Hughes T.K., Smith E.M., and Blalock J.E. Role of leukocyte-derived pro-opiomelanocortin peptides in endotoxin shock. Circ. Shock 35 (1991) 181-191
198. Hardie E.M., and Kruse-Eliott K. Endotoxic shock. Part II: A review of treatment. J. Vet. Intern. Med. 4 (1990) 306-314
199. Hay I.D., Bayer M.F., Kaplan M.M., Klee G.G., Larson P.R., and Spencer C.A. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin. Chem. 37 (1991) 2002-2008
200. Henson P.M., Larsen G.L., Webster R.O., Mitchell B.C., Goins A.J., and Henson J. Pulmonary microvascular alterations and injury induced by complement fragments: Synergistic effect of complement activation, neutrophil sequestration, and prostaglandins. Ann. N. Y. Acad. Sci. 384 (1982) 287-300
201. Herbertson M.J., Werner H.A., and Walley K.R. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am. J. Physiol. 270 (1996) H1979-H1984
202. Hermus A.R.M.M., and Sweep C.G.J. Cytokines and the hypothalamic-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 37 (1990) 867-871
203. Hesselvik J.F., Blombäck M., Brodin B., and Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: Relation to outcome. Crit. Care Med. 17 (1989) 724-733
204. Heuer H.O., Darius H., Lohmann H.F., Meyer J., Schierenberg M., and Treese N. Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 26 (1991) 1381-1385
205. Hinder F., Booke M., Traber L.D., Matsumoto N., Nishida K., Rogers S., and Traber D.L. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit. Care Med. 24 (1996) 131-136
206. Hinshaw L.B. Sepsis/septic shock: Participation of the microcirculation: An abbreviated review. Crit. Care Med. 24 (1996) 1072-1078
207. Holiday J.W., and Faden A.I. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia, and hypoventilation in spinal shock. Brain Res. 19 (1980) 295-299
208. Hollenberg S.M., and Cunnion R.E. Endothelial and vascular smooth muscle function in sepsis. J. Crit. Care 9 (1994) 262-280
209. Howard M., Machamuel T., Andrade S., and Menon S. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177 (1993) 1205-1208
210. Hsu B.R., and Kuhn R.W. The role of the adrenal in generating the diurnal variation in circulating levels of corticosteroid-binding globulin in the rat. Endocrinology 122 (1988) 421-426
211. Hsu D., Moore K.W., and Spits H. Differential effects of IL-4 and IL-10 on IL-2 induced IFN-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4 (1992) 563-569
212. Hugli T.E., Marceau F., and Lundberg C. Effect of complement fragments on pulmonary and vascular smooth muscle. Am. Rev. Respir. Dis. 135 (1987) S9-S13
213. 2 levels increase in patients with burns. J. Am. Coll. Surg. 180 (1995) 318-322
214. Iba T., Yagi Y., Kidokoro A., Fukunaga M., and Fukunaga T. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg. Today 25 (1995) 585-590
215. Imura H., and Fukata J. Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation. Eur. J. Endocrinol. 130 (1994) 32-37
216. Ishii H., Uchiyama H., and Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65 (1991) 618-623
217. Iversen L. Substance P. Br. Med. Bull. 38 (1982) 277-282
218. Jäättelä M. Overexpression of major heat shock protein HSP70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J. Immunol. 151 (1993) 4286-4294
219. Jablons D.M., Mule J.J., and McIntosh J.K. IL-6/IFN-ß-2 as a circulating hormone. J. Immunol. 142 (1989) 1542-1547
220. Jansen M.J.J.M., Hendriks T., Vogels M.T.E., van der Meer J.W.M., and Goris R.J.A. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit. Care Med. 24 (1996) 1196-1202
221. Jansen P.M., Pixley R., Brouwer M., De Jong I.W., Chang A., Hack C., Taylor F.B., and Colman R.W. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 15 (1996) 2337-2344
222. Jaume J.C., Mendel C.M., Frost P.H., Greenspan F.S., and Laughton C.W. Extremely low doses of heparin release lipase activity into plasma and can thereby cause artifactual elevations in serum free thyroxine concentration as measured by equilibrium dialysis. Thyroid 6 (1996) 79-84
223. Jebsen S., Herlevsen P., Knudsen P., Bud M.I., and Klausen N.O. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective randomized, placebo-controlled study. Crit. Care Med. 20 (1992) 918-923
224. Jessop D.S., Chowdrey H.S., Larson P.J., and Lightman S.L. Substance P: Multifunctional peptide in the hypothalamo-pituitary system?. J. Endocrinol. 132 (1992) 331-337
225. Johnson A.D., Berberian P.A., and Bond M.G. Effect of heat shock proteins on survival of isolated aortic cells from normal and atherosclerotic cynomolgus macaques. Atherosclerosis 84 (1990) 111-119
226. Jolliet P., Slosman D.O., and Polla B.S. Heat shock proteins in critical illness: Markers of cellular stress or more?. In: Vincent J.L. (Ed). "Yearbook of Intensive Care and Emergency Medicine" (1994), Springer-Verlag, Berlin 24-34
227. Julou-Schaeffer G., Gray G.A., Fleming I., Schott C.C., Parratt J.R., and Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259 (1990) H1038-H1043
228. Kalter E.S., Daha M.R., Ten Cate J.W., Verhoef J., and Bouma B.N. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J. Infect. Dis. 151 (1985) 1019-1027
229. Kaptein E.M., Egodage P.M., Hoopes M.T., and Burger A.G. Amiodarone alters thyroxine transfer and distribution in humans. Metabolism 37 (1988) 1107-1113
230. Kaptein E.M., MacIntyre S.S., Weiner J.M., Spencer C.A., and Nicoloff J.T. Free thyroxine estimates in nonthyroidal illness: Comparison of eight methods. J. Clin. Endocrinol. Metab. 52 (1981) 1073-1077
231. Katz Y., and Strunk R.C. Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblastis is decreased by IL-4. J. Immunol. 144 (1990) 4675-4680
232. Kawamura M., Terashita Z., Imura Y., Shino A., and Nishikawa K. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation. Thromb. Res. 70 (1993) 281-293
233. Kawamura M., Kitayoshi T., Terashita Z., Fujiwara S., Takatani M., and Nishikawa K. Effects of TCV, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs. J. Lipid Mediat. Cell Signal. 9 (1994) 255-265
234. Kidokoro A., Iba T., Fukunaga M., and Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 5 (1996) 223-228
235. Kietzmann D., Kahl R., Müller M., Burchardi H., and Kettler D. Hydrogens peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med. 19 (1993) 78-81
236. G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3629-3632
237. Klabunde R.E., and Calvello C. Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor. Shock 4 (1995) 368-372
238. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., and Waltersdorph A.M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136 (1986) 4220-4225
239. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: A severity of disease classification system. Crit. Care Med. 13 (1985) 818-829
240. Knaus W.A., Wagner D.P., Draper E.A., Zimmerman J.E., Bergner M., Bastos P.G., Sirio C.A., Murphy D.J., Lotring T., Damiano A., and Harrell Jr. F.I. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100 (1991) 1619-1636
241. Kohan D.E. Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol. Dial. Transplant. 9-4 (1994) 73-77
242. Kox W.J., Bone R.C., Krausch D., Docke W.D., Nüden Kox S., Wauer H., Egerer K., Querner S., Asadullah K., von Baehr R., and Volk H.D. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. Arch. Intern. Med. 157 (1997) 389-393
243. Kragsbjerg P., Holmberg H., and Vikerfors T. Serum concentration of interleukin-6, tumour necrosis factor-α, and C-reactive protein in patients undergoing major operations. Eur. J. Surg. 161 (1995) 17-22
244. Kruithof E.K.O. Plasminogen activator inhibitors. Enzyme 40 (1988) 113-121
245. Kuipers B., Van der Poll T., Levi M., Van Deventer S.J., Ten Cate H., Imai Y., Hack C.R., and Ten Cate J.W. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. J. Immunol. 152 (1994) 2438-2446
246. Lai K.N., Li P.K.T., Woo K.S., Lui S.F., Leung J.C.K., Law E., and Nicholls M.G. Vasoactive hormones in uremic patient on continuous ambulatory peritoneal dialysis. Clin. Nephrol. 35 (1991) 218-223
247. Lamy M., and Deby-Dupont G. Is sepsis a mediator-inhibitor mismatch?. Intensive Care Med. 21 (1995) s250-s257
248. Laragh J.H. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N. Engl. J. Med. 313 (1985) 1330-1340
249. Le J., and Vilcek J. Interleukin 6, a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61 (1989) 588-602
250. Leff J.A., Parsons P.E., and Day C.E. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341 (1993) 777-780
251. Leff J.A., Parsons P.E., Day C.E., Moore E.E., Oppegard M.A., and Repine J.E. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 146 (1992) 985-989
252. Leithäuser B., Matthias F.R., Nicolai U., and Voss R. Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Intensive Care Med. 22 (1996) 631-636
253. Lephart E.D., Baxter C.R., and Parker C.R. Effect of burn trauma on adrenal and testicular steroid hormone production. J. Clin. Endocrinol. Metab. 64 (1986) 842-848
254. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., and Burnett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325 (1991) 997-1001
255. Lerman A., Hildebrand Jr. F.L., Aarhus L.L., and Burnett Jr. J.C. Endothelin has biological actions at pathophysiological concentrations. Circulation 83 (1991) 1808-1814
256. Lerman A., Hildebrand Jr. F.L., Margulies K.B., O'Murchu B., Perrella M.A., Heublein D.M., Schwab T.R., and Burnett Jr. J.C. Endothelin: A new cardiovascular regulatory peptide. Mayo Clin. Proc. 65 (1990) 1441-1455
257. Levi M., Ten Cate H., Van der Poll T., and Van Deventer S.J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270 (1993) 975-979
258. Libert C., Brouckaert P., Shaw A., and Fiers Q. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur. J. Immunol. 20 (1990) 691-694
259. Lorente J.A., Landin L., de Pablo R., Renes E., and Liste D. L-Arginine pathway in the sepsis syndrome. Crit. Care Med. 21 (1993) 1287-1295
260. Lorente J.A., Garcia-Frade L., Landin L., De Pablo R., Torrado C., Renes E., and Garcia-Avello A. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103 (1993) 1536-1542
261. Lowenstein C.J., Dinerman J.L., and Snyder S.H. Nitric oxide: A physiologic messenger. Ann. Intern. Med. 120 (1994) 227-237
262. Lubbesmeyer H.J., Woodson L., Traber L.D., Flynn J.T., Herndon D.N., and Traber D.L. Immunoreactive atrial natriuretic factor is increased in ovine model of endotoxemia. Am. J. Physiol. 254 (1988) R567-R571
263. Lucore C.L. Regulation of fibrinolysis by vascular endothelium. Coron. Artery Dis. 2 (1991) 157-166
264. Lundberg J.M., Franco-Ceresceda A., Lacroix L.S., and Pernow J. Neuropeptide Y and sympathetic neurotransmission. Ann. N.Y. Acad. Sci. 611 (1990) 166-174
265. Lundblad R., and Giercksky K.E. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit. Care Med. 23 (1995) 1382-1390
266. Luppa P., Munker R., Nagel D., Weber W., and Engelhardt D. Serum androgens in intensive-care patients: Correlation with clinical findings. Clin. Endocrinol. 34 (1991) 305-310
267. Lynn W.A., and Cohen J. Adjunctive therapy for septic shock: A review of experimental approaches. Clin. Infect. Dis. 20 (1995) 143-158
268. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int. 49 (1996) 1732-1737
269. Maier R.V., Hahnel G.B., and Fletcher J.R. Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J. Surg. Res. 52 (1992) 258-264
270. De Maio A., and Buchman T.G. Molecular biology of circulary shock. Part IV. Translation and secreation of HEP G2 cell proteins are independently attenuated during heat shock. Circ. Shock 34 (1991) 329-335
271. Mallat A., and Lotersztajn S. Multiple hepatic functions of endothelin-1: Physiopathological relevance. J. Hepatol. 25 (1996) 405-413
272. Mallet E., Lanse X., Devaux A.M., Ensel P., Basuyau J.P., and Brunelle P. Hypercalcitoninaemia in fulminant meningococcaemia in children. Lancet 1 (1983) 294
273. Mammen E.F. Perspectives for the future. Intensive Care Med. 19 (1993) S29-S34
274. Marchant A., Vincent J.L., and Goldman M. The protective role of interleukin-10 in sepsis. In: Vincent J.-L. (Ed). "Yearbook of Intensive Care and Emergency Medicine" (1994), Springer-Verlag, Berlin 42-48
275. Marchant A., Devière J., Byl B., de Groote D., Vincent J.-L., and Goldman M. Interleukin-10 production during septicaemia. Lancet 343 (1994) 707-708
276. Marchant, A., Bruyns, C., Vandenabeele, P., Abramowicz, D., Gerard, C., Delvaux, A., Ghezzi, P., Velu, T., and Goldman, M., Interleukin-10 differentially regulates cytokine production during murine endotoxin shock. 33rd Interscience Conference on Antimicrobial Agent and Chemotherapy, New Orleans, 12 (Abst) (1993)
277. Marecaux G., Pinsky M.R., Dupont E., Kahn R.J., and Vincent J.L. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med. 22 (1996) 404-408
278. Marshall J.C. Infection and host septic response: Implications for clinical trials of mediator antagonism. In: Vincent J.-L. (Ed). "Yearbook of Intensive Care and Emergency Medicine" (1994), Springer-Verlag, Berlin 3-13
279. Martich G.D., Boujoukos A.J., and Suffredini A.F. Response of man to endotoxin. Immunobiology 187 (1993) 403-416
280. Masaki T., Yanagisawa M., Goto K., and Kimura S. Role of endothelin in mechanisms of local blood pressure control. J. Hypertens. 8 (1990) s107-s112
281. Mason R.T., Peterfreund R.A., Sawchenko P.E., Corrigan A.Z., Rivier J.E., and Vale W.W. Release of the predicted calcitonin gene-related peptide from cultured rat trigeminal ganglion cells. Nature 308 (1984) 653-655
282. Massignon D., Lepape A., Bienvenu J., Barbier Y., Boileau C., and Coeur P. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 24 (1994) 36-48
283. Mathison J.C., Wolfson E., and Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81 (1988) 11925-11937
284. McMillen M.A., Huribal M., Cunningham M.E., Kumar R., and Sumpio B.E. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Crit. Care Med. 23 (1995) 34-40
285. Meduri G.U., Headley S., Kohler G., Stentz F., Tolley E., Umberger R., and Leeper K. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest 107 (1995) 1062-1073
286. Meinhold H., Gramm H.J., Meissner W., Zimmermann J., Schwander J., Dennhardt R., and Voigt K. Elevated serum diiodotyrosine (DIT) in severe infections and sepsis: DIT, a possible new marker of leukocyte activity. J. Clin. Endocrinol. Metab. 72 (1991) 945-953
287. Melby J.C., and Spink W.W. Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J. Clin. Invest. 37 (1958) 1791-1798
288. Melby J.C., Egdhal R.H., and Spink W.W. Secretion and metabolism of cortisol after injection of endotoxin. J. Lab. Clin. Med. 56 (1960) 50-62
289. Meli R., Gualillo O., Mattace R., and Di Carlo R. Further evidence for the involvement of prolactin in the inflammatory response. Life Sci. 53 (1993) 105-110
290. Melmed S., Geola F.L., Reed A.W., Pekary A.E., Park J., and Hershman J.M. A comparison of methods for assessing thyroid function in nonthyroidal illness. J. Clin. Endocrinol. Metab. 54 (1982) 300-306
291. Mendel C.M., Laughton C.W., McMahon F.A., and Cavalieri R.R. Inability to detect an inhibitor to thyroxine-serum protein binding in sera from patients with nonthyroidal illness. Metabolism 40 (1991) 152-159
292. Mengozzi M., Fantuzzi G., Faggioni R., Marchant A., Goldman M., Orencole S., Clark B.D., Sironi M., Benigni F., and Ghezzi P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology 82 (1994) 207-210
293. Meyer J., Hinder F., Stothert J., Traber L.D., Herndon D.N., Flynn J.T., and Traber D.L. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J. Appl. Physiol. 76 (1994) 2785-2793
294. Michie H.R., Manoque K.R., Spriggs D.R., Revhaugh A.O., Wijer S.T., Diharello C.A., Cerami A., Wolff S.M., and Willmore D.W. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 (1988) 1481-1486
295. Michie H.R., Spriggs D.R., Manogue K.R., Sherman M.L., Revhaug A., O'Dwyer S.T., Arthur K., Dinarello C.A., Cerami A., Wolff S.M., Kufe D.W., and Wilmore D.W. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104 (1988) 280-286
296. Miller E.J., Cohen A.B., and Matthay M.A. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit. Care Med. 24 (1996) 1448-1454
297. Mitaka C., Nagura T., Sakanishi N., Tsunoda Y., and Toyooka H. Plasma α-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study. Crit. Care Med. 18 (1990) 1201-1203
298. Miyauchi T., Tomobe Y., Shiba R., Ishikawa T., Yanagisawa M., Kimura S., Sugishita Y., Ito I., Goto K., and Masaki T. Involvement of endothelin in the regulation of human vascular tonus. Circulation 81 (1990) 1874-1880
299. Moldawer L.L. Biology of proinflammatory cytokines and their antagonists. Crit. Care Med. 22 (1994) S3-S7
300. Molloy R.G., Mannick J.A., and Rodrick M.L. Cytokines, sepsis and immunomodulation. Br. J. Surg. 80 (1993) 289-297
301. Moncada S., and Higgs A. The L-Arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
302. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Eur. J. Clin. Invest. 21 (1991) 361-374
303. Moore J.M., Earnest M.A., DiSimone A.G., Abumrad N.N., and Fletcher J.R. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia. Circ. Shock 35 (1991) 53-59
304. Morel D.R., Lacroix J.S., Hemsen A., Steinig D.A., Pittet J.F., and Lundberg J.M. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol. 167 (1989) 427-428
305. Morise Z., Ueda M., Aiura K., Endo M., and Kitajima M. Pathophyiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115 (1994) 199-204
306. Morris H.R., Panico M., Etienne T., Tippinss J., Girgis I., and MacIntre I. Isolation and characterization of human calcitonin gene-related peptide. Nature 308 (1984) 746-748
307. Morris M.J., Russel A.E., Kapoor V., Cain M.D., Elliot J.M., West M.J., Wing L.M.H., and Chalmres J.P. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J. Auton. Nerv. Syst. 17 (1986) 143-149
308. Morrison D.C., and Cochrane C.G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J. Exp. Med. 140 (1974) 797-811
309. Morrison D.C., Lei M.-G., Kirikae T., and Chen T.-Y. Endotoxin receptors on mammalian cells. Immunobiology 187 (1993) 212-226
310. Le Moullec J.M., Jullienne A., Lasmoles J.C., Guliana J.M., Milhaud G., and Moukhtar M.S. The complete sequence of human preprocalcitinin. FEBS Lett. 167 (1984) 93-97
311. Murphy W.J., Rui H., and Longo D.L. Effects of growth hormone and prolactin; immune development and function. Life Sci. 57 (1995) 1-14
312. Myhre U., Pettersen J.T., Rise C., and Giercksky K.E. Endothelin-1 and endotoxemia. J. Cardiovasc. Pharmacol. 22 (1993) s291-s294
313. Nakamoto H., Suzuki H., Murakami M., Kageyama Y., Naitoh M., Sakamaki Y., Ohishi A., and Saruta T. Different effects of low and high doses of endothelin on haemodynamics and hormones in the normotensive conscious dog. J. Hypertens. 9 (1991) 337-344
314. Nakashima Y., Sueishi K., and Tanaka K. Thrombin enhances production and release of tissue plasminogen activator from bovine venous endothelial cells. Fibrinolysis 2 (1988) 227-234
315. Naruse M., Obana K., Naruse K., Yamaguchi H., Demura H., Inagami T., and Shizume K. Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue. J. Clin. Endocrinol. Metab. 64 (1987) 10-16
316. Nathan C. Natural resistance and nitric oxide. Cell 82 (1995) 873-876
317. Nava E., Palmer M.J., and Moncada S. Inhibition of nitric oxide synthesis in septic shock: How much is beneficial?. Lancet 338 (1991) 1555-1557
318. Nawroth P.P., and Stern D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163 (1986) 740-745
319. Niedbala M.J. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl. 42 (1993) 179-193
320. Nootens M., Kaufmann E., Rector T., Toher C., Judd D., Francis G.S., and Rich S. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels. J. Am. Coll. Cardiol. 26 (1995) 1581-1585
321. Nuijens J.H., Huijbregts C.C., Eerenberg-Belmer A.J., Abbink J.J., Strack Van Schijndel R.J., Felt-Bersma R.J., Thijs L.G., and Hack C.E. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C-inhibitor complexes in sepsis. Blood 72 (1988) 1841-1848
322. Nuijens J.H., Eerenberg-Belmer A.J., Huijbregts C.C., Schreuder W.O., Felt-Bersma R.J., Abbink J.J., Thijs L.G., and Hack C.E. Proteolytic inactivation of plasma C1 inhibitor in sepsis. J. Clin. Invest. 84 (1989) 443-450
323. Ochoa J.B., Udekwu A.O., Billiar T.R., Curran R.D., Cerra F.B., Simmons R.L., and Peitzman A.B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214 (1991) 621-626
324. Oelkers W. Adrenal insufficiency. N. Engl. J. Med. 335 (1997) 1206-1212
325. Van Oers J.W.A.M., Tilders F.J.H., and Berkenbosch F. Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor. Endocrinology 124 (1989) 1239-1246
326. Olster D.H., and Ferin M. Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey. J. Clin. Endocrinol. Metab. 65 (1987) 261-267
327. O'Halloran D.J., and Bloom S.R. Calcitonin gene related peptide. A major neuropeptide and the most powerful vasodilator known. Br. Med. J. 302 (1991) 739-740
328. Ohlsson K., Bjorn P., Bergenfeldt M., Hageman R., and Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348 (1990) 550-552
329. Ono S., Mochizuki H., and Tamakuma S. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am. J. Surg. 171 (1996) 409-415
330. Ota K., Kimura T., Shoji M., Inoue M., Sato K., Ohta M., Yamamoto T., Tsunoda K., Abe K., and Yoshinaga K. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function. Am. J. Physiol. 262 (1992) E135-E141
331. Ou M.C., Kambayashi J., Kawasaki T., Uemura Y., Shinozaki K., Shiba E., Sakon M., Yukawa M., and Mori T. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure. Thromb. Res. 73 (1994) 227-238
332. Pacher R., Stanek B., Hülsmann M., Koller-Strametz J., Berger R., Schuller M., Hartter E., Ogris E., Frey B., Heinz G., and Maurer G. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J. Am. Coll. Cardiol. 27 (1996) 633-641
333. Padalino P., Gardinali M., Pallavicini J., Chiara O., Bisiani G., and Nespoli A. Complement activation and endotoxin in sepsis. Prog. Clin. Biol. Res. 308 (1989) 277-282
334. Parillo J.E. Management of septic shock: Present and future. Ann. Intern. Med. 115 (1991) 491-493
335. Parillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., and Ognibene F.P. Septic shock in humans. Ann. Intern. Med. 113 (1990) 227-242
336. Parker L.N., Levin E.R., and Lifrak E.T. Evidence for adrenocortical adaptation to severe illness. J. Clin. Endocrinol. Metab. 60 (1985) 947-952
337. Pastor C.M., and Billiar T.R. Regulation and functions of nitric oxide in the liver in sepsis and inflammation. New Horiz. 3 (1995) 65-72
338. Payen D., Bernard C., and Beloucif S. Nitric oxide in sepsis. Clin. Chest Med. 17 (1996) 333-350
339. Pernow J., Hemsen A., and Lundberg J.M. Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol. Scand. 137 (1989) 317-318
340. Petraglia F., Vale W., and Rivier C. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. Endocrinology 119 (1986) 2445-2450
341. Philip R., and Epstein L.B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323 (1986) 86-89
342. Pinsky M.R., Vincent J.-L., Deviere J., Alegre M., Kahn R.J., and Dupont E. Serum cytokine levels in human septic shock. Chest. 103 (1993) 565-575
343. Pittet J.-F., Morel D.R., Hemsen A., Gunning K., Lacroix J.-S., Suter P.M., and Lundberg J.M. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg. 213 (1991) 261-264
344. Pober J.S., Bevilacqua M.P., Mendrick D.L., Lapierre L.A., Fiers W., and Gimbrone M. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 137 (1986) 1893-1896
345. Pohl W., Kindas-Mugge J., Kohn H., Fitzal S., Micksche M., and Kummer F. Elevated heat shock protein 72 expression by human alveolar macrophages during the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147 (1993) A70 (Abst)
346. van der Poll T., Romijn J.A., Wiersinga W.M., and Sauerwein H.P. Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab. 71 (1990) 1567-1572
347. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., and Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest. 97 (1996) 713-719
348. van der Poll T., Levi M., Van Deventer S.J., Ten Cate H., Haagmans B.L., Biemond B.J., Buller H.R., Hack C.E., and Ten Cate J.W. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83 (1994) 446-451
349. van der Poll T., Levi M., Hack C.E., Ten Cate H., Van Deventer S.J., Eerenberg A.J., De Groot E.R., Jansen J., Gallati H., Buller H.R., Ten Cate J.W., and Aarden L.A. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J. Exp. Med. 179 (1994) 1253-1259
350. Pottemeyer E., Vassar M.J., and Holcroft J.W. Coagulation, inflammation and response to injury. Crit. Care Clin. 2 (1986) 683-702
351. Pradier O., Gerard C., Delvaux A., Lybin M., Abramowicz D., Capel P., Velu T., and Goldman M. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopoysaccharide. Eur. J. Immunol. 23 (1993) 2700-2703
352. Pruitt J.H., Burress Welborn M., Edwards P.D., Harward T.R.S., Seeger J.W., Martin T.D., Smith C., Kenney J.A., Wesdorp R.I.C., Meijer S., Cuesta M.A., Abouhanze A., Copeland E.M., Giri J., Sims J.E., Moldawer L.L., and Oldenburg H.S.A. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87 (1996) 3282-3288
353. Raff H., and Findling J.W. Aldosterone control in critically ill patients: ACTH, metoclopropamide, and atrial natriuretic peptide. Crit. Care Med. 18 (1990) 915-920
354. Rainger E.S., Wautier M.P., Nash G.B., and Wautier J.L. Prolonged E-selectin induction by monocytes potentiates the adhesion of flowing neutrophil to cultured endothelial cells. Br. J. Haematol. 92 (1996) 192-199
355. Redl H., Bahrami S., Schlag G., and Traber D.L. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187 (1993) 330-345
356. Rees D.D., Cellek S., Palmer R.M.J., and Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173 (1990) 541-547
357. Reincke M., Allolio B., Würth G., and Winkelmann W. The hypothalamic-pituitary-adrenal axis in critical illness: Response to dexamethasone and corticotropin releasing hormone. J. Clin. Endocrinol. Metab. 77 (1993) 151-156
358. Richmand D.A., Molitch M.E., and O'Donnell T.F. Altered thyroid hormone levels in bacterial sepsis: The role of nutritional adequacy. Metabolism 29 (1980) 936-939
359. Rivier C. Role of interleukins in the stress response. In: Jasmin G., and Cantin M. (Eds). "Stress Revisited. 1. Neuroendocrinology of Stress" 14 (1991), Karger, Basel 63-79
360. Rivier C., and Vale W. Influence of corticotropin-releasing factor on reproductive function in the rat. Endocrinology 114 (1984) 914-921
361. Rivier C., and Vale W. Stimulatory effects of interleukin-1 on adrenocorticotropin secretion in the rat: Is it modulated by prostaglandins?. Endocrinology 129 (1991) 384-388
362. Rivier C., Chizzonite R., and Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology 125 (1989) 2800-2805
363. Rixen S., Siegel J.H., and Friedman H.P. "Sepsis/SIRS," physiologic classification, severity stratification, relation to cytokine elaboration and outcome prediction in posttrauma critical illness. J. Trauma 41 (1996) 581-598
364. Rocha D.M., Santeusanio F., Faloona G.R., and Unger R.H. Abnormal pancreatic alpha-cell function in bacterial infections. N. Engl. J. Med. 288 (1973) 700-703
365. Rogy M.A., Coyle S.M., Oldenburg H.S., Barie P.S., van Zee K.J., Smith C.G., Moldawer L.L., and Lowry S.F. Persistently elevated soluble TNF receptor and IL-1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 178 (1994) 132-138
366. Rolih C.A., and Ober K.P. The endocrine response to critical illness. Med. Clin. North Am. 79 (1995) 211-224
367. Rosenbloom A.J., Pinsky M.R., Bryant J.L., Shin A., Tran T., and Whiteside T. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. JAMA 274 (1995) 58-65
368. Ross R., Miell J., Freeman E., Jonest J., Matthews D., Preece M., and Buchanan C. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin. Endocrinol. 35 (1991) 47-54
369. Ross R.J., Miell J.P., Holly J.M.P., Maheshwari H., Norman M., Farhana Abdulla A., and Buchanant C.R. Levels of GH binding activity, IGFBP-I, insulin, blood glucose, and cortisol in intensive care patients. Clin. Endocrinol. 35 (1991) 361-367
370. Russell D.H. New aspects of prolactin and immunity: A lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol. Sci. 10 (1989) 40-44
371. Sala N., Fontcuberta J., and Rutllant M.L. New biological concepts on coagulation inhibitiors. Intensive Care Med. 19 Suppl 1 (1993) S3-S7
372. Salvemini D., Korbut R., Anggard E., and Vane J. Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.SA. 87 (1990) 2593-2597
373. Samson W.K., Aguila M.C., Martinovic J., Antunes-Rodrigues J., and Norris M. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion. Peptides 8 (1987) 449-454
374. Sanai L., Haynes W.G., MacKenzie A., Grant I.S., and Webb D.J. Endothelin production in sepsis and the adult respiratory distress syndrome. Intensive Care Med. 22 (1996) 52-56
375. Schade U.F. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ. Shock 31 (1990) 171-181
376. Schapira M., Gardaz J.P., Py P., Lew P.D., Perrin L.H., and Suter P.M. Prekallikrein activation in the adult respiratory distress syndrome. Bull. Eur. Physiopathol. Respir. 21 (1995) 237-241
377. Schein R.M.H., Sprung C.L., Marcial E., Napolitano L., and Chernow B. Plasma cortisol levels in patients with septic shock. Crit. Care Med. 18 (1990) 259-263
378. Schell D.A., Vari R.C., and Samson W.K. Adrenomedullin: A newly discovered hormone controlling fluid and electrolyte homeostasis. Trends Endocrinol. Metab. 7 (1996) 7-13
379. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., and Dinarello C.A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75 (1990) 40-47
380. Schlechte J.A., and Hamilton D. The effect of glucocorticoids on corticoisteroid binding globulin. Clin. Endocrinol. 27 (1991) 197-203
381. Schneider F., Lutun P., Couchot A., Bilbault P., and Tempe J.D. Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med. 19 (1993) 99-104
382. Schoemaker W.C., Appel P.L., Kram H.B., Bishop M.H., and Abraham E. Sequence of physiologic patterns in surgical septic shock. Crit. Care Med. 21 (1993) 1876-1889
383. Schoeninger L.O., Reilly P.M., Bulkley G.B., and Buchman T.G. Heat-shock gene expression excludes hepatic acute phase expression after resuscitation from haemorrhagic shock. Surgery 112 (1992) 355-363
384. Scholz W., McClurg M.R., Cardenas G.J., Smith M., Noonan D.J., Hugli T.E., and Morgan E.L. C5a-mediated release of interleukin 6 by human monocytes. Clin. Immunol. Immunopathol. 57 (1990) 297-307
385. Schurr M.J., Fabian T.C., Croce M.A., Varnavas L.E., and Proctor K.G. Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock. Shock 7 (1979) 55-59
386. Selye H. A syndrome produced by diverse nocuous agents. Nature 138 (1936) 32
387. Semple C.G., Gray C.E., and Beastall G.H. Adrenal androgens and illness. Acta Endocrinol. (Copenh) 116 (1987) 155-160
388. Shalaby M.R., Waage A., Aarden L.A., and Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53 (1989) 448-498
389. Sherry R.M., Cue J.I., Goddard J.K., Parramore J.B., and DiPiro J.T. Interleukin-10 is associated with the development of sepsis in trauma patients. J. Trauma 40 (1996) 613-616
390. Sheth S.B., and Carvalho A.C. Protein S and C alterations in acutely ill patients. Am. J. Hematol. 36 (1991) 14-19
391. Sibbald W.J., Short A., Cohen M.P., and Wilson R.F. Variation in adrenocortical responsiveness during severe bacterial infections. Ann. Surg. 186 (1977) 29-33
392. Silva O., Becker K.L., Shalhoub R.J., Snider R.H., Bivins L.E., and Moore C.F. Calcitonin levels in chronic renal disease. Nephron 19 (1977) 12-18
393. Sironi M., Munoz C., Pollicino T., Siboni A., Sciacca F.L., Bernasconi S., Vecchi A., Colotta F., and Montavani A. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur. J. Immunol. 23 (1993) 2692-2695
394. Slag M.F., Morley J.E., Elson M.K., Labrosse K.R., Crowson T.W., Nuttall F.Q., and Shafer R.B. A comparison of currently available assays. Free thyroxine levels in critically ill patients. JAMA 246 (1981) 2702-2706
395. van der Sluijs Veer G., Vermes I., and Bonte H.A. Diagnostic performance of a modified freethyroxin assay in subjects with anomalies in their binding proteins. Clin. Chem. 35 (1989) 493
396. van der Sluijs Veer G., Vermes I., Bonte H.A., and Hoorn R.K.A. Temperature effects on free-thyroxine measurements: Analytical and clinical consequences. Clin. Chem. 38 (1992) 1327-1331
397. Snyder S.H., and Bradt D.S. Biological roles of nitric oxide. Sci. Am. 266 (1992) 28-35
398. Soni A., Pepper G.M., Wyrwinski P.M., Ramirez N.E., Simon R., Pina T., Gruenspan H., and Vaca C.E. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am. J. Med. 98 (1995) 266-271
399. Span L.F.R., Hermus A.R.M.M., Bartelink A.K.M., Hoitsma A.J., Gimbrère J.S.F., Smals A.G.H., and Kloppenborg P.W.C. Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med. 18 (1992) 93-96
400. Spooren P.F.M.J., Vermes I., Kip L., and Haanen C. Endothelin: A possible role in the occurrence of renal failure in thrombotic thrombocytopenic purpura. Thromb. Haemost. 69 (1993) 401-403
401. Spratt D.I., Bigos S.T., Beitins I., Cox P., Longcope C., and Orav J. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: Bio- and immunoreactive gonadotropins. J. Clin. Endocrinol. Matab. 75 (1992) 1562-1570
402. Starnes H.F., Pearee M.K., Tewari A., Yim H.H., Zou J.C., and Ambrams J.S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145 (1990) 4185-4191
403. Stasch J.P., Hirth-Dietrich C., Kazda S., and Neuser D. Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo. Life Sci. 45 (1989) 869-875
404. Stepanas A.V., Samaan N.A., Hill C.S., and Hickey R.C. Medullary thyroid carcinoma. Cancer 43 (1979) 825-837
405. Stevens J.H., O'Hanley P., Shapiro J.M., Mihm F.G., Satoh P.S., Collins J.A., and Raffin T.A. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77 (1986) 1812-1816
406. Stüber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24 (1996) 381-384
407. Sundsmo J.S., and Fair D.S. Relationship among the complement, kinin, coagulation and fibrinolytic systems. Springer Semin. Immunopathol. 6 (1983) 127-175
408. Surks M.I., Hupart K.H., Pan C., and Shapiro L.E. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. J. Clin. Endocrinol. Metab. 67 (1988) 1031-1039
409. Szabó C. Alternations in nitric oxide production in various forms of circulatory shock. New Horiz. 3 (1995) 2-32
410. Takakuwa T., Endo S., Nakae H., Suzuki T., Inada K., Yoshida M., Ogawa M., and Uchida K. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84 (1994) 271-281
411. Tatemoto K., and Neuropeptide Y. Complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA 79 (1982) 5485-5489
412. Taylor Jr. F.B. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: Regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor. Prog. Clin. Biol. Res. 388 (1994) 175-194
413. Taylor Jr. F.B., Chang A.C., Ruf W., Morrissey J.H., Hinshaw L., Catlett R., Blick K., and Edgington T.S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ. Shock 33 (1991) 127-134
414. Thijs L.G., and Hack C.E. Time course of cytokine levels in sepsis. Intensive Care Med. 21 (1995) s258-s263
415. Thijs L.G., De Boer J.P., De Groot M.C., and Hack C.E. Coagulation disorders in septic shock. Intensive Care Med. 19 Suppl 1 (1993) S8-S15
416. Thompson W.A., Coyle S., Van Zee K., Oldenburg H., Trousdale R., Rogy M., Felsen D., Moldawer L., and Lowry S.F. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. Arch. Surg. 129 (1994) 72-79
417. Tidgren B., Theodorsson E., and Hjemdahl P. Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans. Clin. Physiol. 11 (1991) 9-19
418. Tilders F.J.H., DeRijk R.H., VanDam A.-M., Vincent V.A.M., Schotanus K., and Persoons J.A.H. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 19 (1994) 209-232
419. Traber D.L. Presence and absence of nitric oxide synthase in sepsis. Crit. Care Med. 24 (1996) 1102-1103
420. Tracey K.J., Beutler B., and Lowry S.F. Shock and tissue injury induced by recombinant human cachectin. Science 234 (1986) 470-474
421. Tracey K.J., Vlassara H., and Cerami A. Cachectin/tumor necrosis factor. Lancet 1 (1989) 1122-1126
422. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., and Kuo G.C. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330 (1987) 662-664
423. Tsuneyoshi I., Kanmura Y., and Yoshimura N. Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit. Care Med. 24 (1996) 1083-1086
424. Uchiba M., Okajima K., Murakami K., Nawa K., Okabe H., and Takatsuki K. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats. Thromb. Haemost. 74 (1995) 1265-1270
425. Vane J.R., Änggard E.E., and Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323 (1990) 27-36
426. 5)-enkephalinamide on the hypothalamus-pituitary-testis function in rats. Neurosci. Lett. 11 (1979) 201-204
427. Vermes I., Spooren P.F.M.J., Kalsbeek-Batenburg E.M., and Haanen C. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetes 36 (1993) 472-473
428. Vermes I., Beishuizen A., Hampsink R.M., and Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J. Clin. Endocrinol. Metab. 80 (1995) 1238-1242
429. Vesely D.L., Blankenship M., Douglass M.A., McCormick M.T., Rodriguez-Paz G., and Schocken D.D. Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans. Life Sci. 59 (1996) 243-254
430. Villar J., Edelson J.D., Post M., Mullen J.B.M., and Slutsky A.S. Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am. Rev. Respir. Dis. 147 (1993) 177-181
431. Voerman H.J., Stehouwer C.D.A., van Kamp G.J., Strack van Schijndel R.J.M., Groeneveld A.B.J., and Thijs L.G. Plasma endothelin levels are increased during septic shock. Crit. Care Med. 20 (1992) 1097-1101
432. Voerman H.J., Strack van Schijndel R.J.M., Groeneveld A.B.J., de Boer H., Nauta J.P., van der Veen E.A., and Thijs L.G. Effect of recombinant human growth hormone in patients with severe sepsis. Ann. Surg. 216 (1992) 648-655
433. Voerman H.J., Groeneveld A.B.J., de Boer H., Strack van Schijndel R.J.M., Nauta J.P., van der Veen E.A., and Thijs L.G. Time course and variability of the endocrine and metabolic response to severe sepsis. Surgery 114 (1993) 951-959
434. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin-10. Curr. Opin. Immunol. 4 (1992) 314-320
435. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., and Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169 (1989) 333-338
436. Waage A., Halstensen A., and Espevik T. Association between tumour necrosis factor in serum and fatal outcome in pateints with meningococcal disease. Lancet 2 (1987) 355-357
437. Wachtfogel Y.T., DeLa Cadena R.A., and Colman R.W. Structural biology, cellular interactions and pathophysiology of the contact system. Thromb. Res. 72 (1993) 1-21
438. Wade C.E., Lindberg J.S., Cockrell J.L., Lamiell J.M., Hunt M.M., Ducey J., and Jurney T.H. Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J. Clin. Endocrinol. Metab. 67 (1988) 223-227
439. 3 with two RIA kits in eight groups of patients. J. Endocrinol. Invest. 8 (1985) 495-500
440. Warren H.S. Strategies for the treatment of sepsis. N. Engl. J. Med. 336 (1997) 952-953
441. Warrens A.N., Cassidy M.J.D., Takahashi K., Ghatei M.A., and Bloom S.R. Endothelin in renal failure. Nephrol. Dial. Transplant. 5 (1990) 418-422
442. Wautier J.L., Pintigny D., Maclouf J., Wautier M.P., Corvazier E., and Caen J. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J. Lab. Clin. Med. 107 (1986) 210-215
443. Weitzberg E., Lundberg J.M., and Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ. Shock 33 (1991) 222-227
444. Wenzel R.P., Pinsky M.R., Ulevitch R.J., and Young L. Current undersanding of sepsis. Clin. Infect. Dis. 22 (1996) 407-413
445. Westendorp R.G.J., Langermans J.A.M., Huizinga T.W.J., Elouali A.H., Verweij C.L., Boomsma D.I., and Vandenbroucke J.P. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349 (1997) 170-173
446. Whichter J.T., and Evans S.W. Cytokines in disease. Clin. Chem. 36 (1990) 1269-1281
447. White J.D. Neuropeptide Y: A central regulator of energy homeostasis. Regul. Pep. 49 (1993) 93-107
448. Wilmore D.W. Catabolic illness: Strategies enhancing recovery. N. Engl. J. Med. 325 (1991) 695-702
449. Wimalawansa S.J. Calcintonin gene-related peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr. Rev. 17 (1996) 533-585
450. Wong G.H.W., Elwell J.H., Oberley L.W., and Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58 (1989) 923-931
451. Wong T.K., and Hershman J.M. Changes in thyroid function in nonthyroid illness. Trends Endocrinol. Metab. 3 (1992) 8-12
452. Wong T.K., Pekary A.E., Hoo G.S., Bradley M.E., and Hershman J.M. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin. Chem. 38 (1992) 720-724
453. Woolf P.D., Hamill R.W., McDonald J.V., Lee L.A., and Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J. Clin. Endocrinol. Metab. 60 (1985) 444-450
454. Yanagisawa M., and Masaki T. Endothelin, a novel endothelium-derived peptide. Biochem. Pharmacol. 38 (1989) 1877-1883
455. Yandle T.G. The natriuretic peptide hormones. Biochemistry of natriuretic peptides. J. Intern. Med. 235 (1994) 561-576
456. Yong R.A. Stress proteins and immunology. Annu. Rev. Immunol. 8 (1990) 401-420
457. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., and Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 89 (1992) 4845-4849
458. Van Zee K.J., DeForge L.E., Fisher E., Marano M.A., Kenney J.S., Remick D.G., Lowry S.F., and Moldawer L.L. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immunol. 146 (1991) 3478-3482
459. de Zegher F., van den Berghe G., Devlieger H., Eggermont E., and Veldhuis J.D. Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr. Res. 34 (1993) 642-645
460. Zenichi M., Masakazu U., Koichi A., Masao E., and Masaki K. Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115 (1994) 199-204
461. Ziegler E.J., Fisher C.J., Sprung C.L., Straube R.C., Sadoff J.C., Foulke G.E., Wortel C.H., Fink M.P., Dellinger R.P., Teng N.N.H., Allen I.E., Berger H.J., Knatterud G.L., LoBuglio A.F., Smith C.R., and The HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N. Engl. J. Med. 324 (1991) 429-436
462. Zimmermann T., Laszik Z., Nagy S., Kaszaki J., and Joo F. The role of the complement system in pathogenesis of multiple organ failure in shock. Prog. Clin. Biol. Res. 308 (1989) 291-297
463. Zipser R.D., Davenport M.W., Martin K.L., Tuck M.L., Warner N.E., Swinney R.R., Davis C.L., and Horton R. Hyperreninemic hypoaldosteronism in the critically ill: A new entity. J. Clin. Endocrinol. Metab. 53 (1981) 867-873
464. Zuckerman S.H., Shellhaas J., and Butler L.D. Differential regulation of lipopolysaccharideinduced interleukin 1 and tumor necrosis factor synthesis: Effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur. J. Immunol. 19 (1989) 301-305